Vimarsana
Biggest News Aggregation in the World

Usfda Approval News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Usfda Approval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Usfda Approval Today - Breaking & Trending Today

lupin: Lupin gets USFDA nod to market generic antifungal tablets - Vimarsana News

lupin: Lupin gets USFDA nod to market generic antifungal tablets

The approval granted by the US Food and Drug Administration (USFDA) for the abbreviated new drug application of Fluconazole tablets in strengths of 50 mg, 100 mg, 150 mg and 200 mg, Lupin said in a regulatory filing.

Zydus gets USFDA approval to market generic acne drug - Vimarsana News

Zydus gets USFDA approval to market generic acne drug

Zydus Lifesciences announced receiving final approval from the US health regulator to commercialize the drug with a market size of $195 million.

Alembic Pharma gets tentative USFDA approval for generic version of Dabigatran Etexilate capsules - Vimarsana News

Alembic Pharma gets tentative USFDA approval for generic version of Dabigatran Etexilate capsules

Alembic Pharma gets tentative USFDA approval for generic version of Dabigatran Etexilate capsules

Zydus Cadila's US Firm Gets US Food And Drug Administration Approval To Market Roflumilast Tablets - Vimarsana News

Zydus Cadila's US Firm Gets US Food And Drug Administration Approval To Market Roflumilast Tablets

Cadlia Healthcare Ltd on Monday said group firm Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market its generic version of Roflumilast tablets in the strength of 500 mcg indicated to reduce the risk of

Source: ndtv.com
Cipla gets USFDA approval to market Lanreotide injection in US market - Vimarsana News

Cipla gets USFDA approval to market Lanreotide injection in US market

The company said it has received final approval for Lanreotide Injection from the US Food and Drug Administration (USFDA)